GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Spectral AI Inc.
Spectral AI is developing an AI-powered device for burn severity assessment. Its stock price is a bet that its technology will improve patient outcomes. The chart reflects progress toward approval and commercialization.
Share prices of companies in the market segment - AI
Spectral AI has developed the DeepViewโข platform, an AI-powered wound image analysis platform that helps doctors determine the need for burn surgery in real time. We've categorized it as part of the "AI" segment. The graph below illustrates the overall dynamics of medical AI, which is changing approaches to diagnostics.
Broad Market Index - GURU.Markets
Spectral AI is a company that uses artificial intelligence to analyze wound images, helping doctors make treatment decisions for burns and other injuries. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the AI โโin medicine sector.
Change in the price of a company, segment, and market as a whole per day
MDAI - Daily change in the company's share price Spectral AI Inc.
Spectral AI, Inc.'s daily stock price reflects volatility in the medical AI technology sector. This metric measures the company's sensitivity to news of the approval and implementation of its wound diagnostic system, providing a valuable element for analysis.
Daily change in the price of a set of shares in a market segment - AI
Spectral AI, Inc. is a medical technology company. This chart shows high volatility. Comparing it to MDAI, which uses AI for wound diagnosis, helps to assess it as a high-risk tech stock.
Daily change in the price of a broad market stock, index - GURU.Markets
Spectral AI uses artificial intelligence to assess burn severity, helping doctors make decisions. This medtech company's stock reflects the growing role of AI in medicine. Its volatility is part of the dynamics of the innovation sector, which influences the entire market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Spectral AI Inc.
Spectral AI, Inc.'s year-over-year performance is a story of AI in medicine. Its 12-month market cap growth reflects progress in commercializing its DeepView device, which uses AI to assess wound healing. Winning government contracts for emergency use is key to its growth.
Annual dynamics of market capitalization of the market segment - AI
Spectral AI, Inc. is developing an AI-powered medical device for wound healing assessment. Its technology is designed to improve physician decision-making. Its stock price is highly volatile, reflecting investor confidence in its breakthrough potential and ability to commercialize its unique technology.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Spectral AI, with its wound analysis platform, is a speculative bet on the future of medicine. Its stock price isn't tied to the economy, but rather driven by scientific breakthroughs and partnerships. The chart tells the story of investors' belief that AI will revolutionize diagnostics.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Spectral AI Inc.
Spectral AI is developing an AI platform for wound healing assessment. Being in the commercialization stage, its monthly valuation is based on expectations. News of regulatory approvals (FDA) and initial hospital contracts are key events shaping its schedule.
Monthly dynamics of market capitalization of the market segment - AI
The use of artificial intelligence in medical diagnostics is a revolutionary trend. The dynamics of this sector, shown in the graph, reflect the enormous expectations for the application of AI in healthcare. Companies like Spectral AI are developing their diagnostic tools in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Spectral AI uses artificial intelligence to assess wounds. It's a bet on the intersection of medicine and AI. The company's stock is volatile, and its performance depends on the adoption of the technology and the hype surrounding AI, rather than on general market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Spectral AI Inc.
The weekly performance of Spectral AI, which is developing a device for AI-powered wound analysis, is speculative. News of FDA approval or military contracts (for burn assessment) could cause sharp price movements.
Weekly dynamics of market capitalization of the market segment - AI
Spectral AI shares, like those of the entire emerging AI sector in medicine, are moving against a backdrop of general news about technological breakthroughs. Investor sentiment toward the entire industry is creating extreme volatility. The chart will reveal whether the company is leading the hype.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Spectral AI shares, like those of the entire emerging AI sector in medicine, are moving against a backdrop of general news about technological breakthroughs. Investor sentiment toward the entire industry is creating extreme volatility. The chart will reveal whether the company is leading the hype.
Market capitalization of the company, segment and market as a whole
MDAI - Market capitalization of the company Spectral AI Inc.
Spectral AI's market capitalization chart represents the financial valuation of a company developing an AI-powered medical device for assessing wound healing. It reflects investor expectations for its potential to treat burns and diabetic ulcers. Its performance since its SPAC exit tells the story of how the market weighs innovative technology against the path to commercialization and FDA approval.
MDAI - Share of the company's market capitalization Spectral AI Inc. within the market segment - AI
Spectral AI uses artificial intelligence for medical diagnostics, specifically to assess burn severity, helping doctors make treatment decisions. Its market share in the AI โโsector reflects its leadership in this narrow but important niche. The chart below shows the importance of this technology in the future of medicine.
Market capitalization of the market segment - AI
Spectral AI uses artificial intelligence to analyze wound images, helping doctors make decisions. The chart below shows the total market capitalization of the entire sector. Its growth reflects the penetration of AI into medicine. Spectral AI technology has the potential to dramatically improve the diagnosis and treatment of burns and ulcers.
Market capitalization of all companies included in a broad market index - GURU.Markets
The artificial intelligence visible in the graph is finding applications in medicine. Spectral AI is developing a device that uses AI to analyze wounds and burns, helping doctors choose treatment methods. Its capitalization is a bet that this technology will improve patient care and reduce costs.
Book value capitalization of the company, segment and market as a whole
MDAI - Book value capitalization of the company Spectral AI Inc.
Spectral AI is the material foundation for artificial intelligence in medicine. Its book value reflects investments in the development and production of the DeepView portable device, which uses AI to assess burn severity. These are physical assets destined to change the standards of wound care.
MDAI - Share of the company's book capitalization Spectral AI Inc. within the market segment - AI
Spectral AI is developing a medical device for wound diagnostics based on artificial intelligence. Its share of the sector's assets consists of R&D facilities and prototypes. The company is building the physical and intellectual foundation for bringing its innovative diagnostic tool to market.
Market segment balance sheet capitalization - AI
Spectral AI, Inc. develops AI-powered medical diagnostic devices. Its model is moderately capital-intensive, requiring R&D centers to develop AI hardware and IT infrastructure, as well as manufacturing facilities. Compared to the medical technology sector, it is more complex than pure software companies.
Book value of all companies included in the broad market index - GURU.Markets
Spectral AI's assets aren't X-rays, but a unique portable device that uses artificial intelligence to instantly assess the severity of a burn and the need for a skin graft. The company's balance sheet reflects the value of this breakthrough technology. The chart shows how much capital has been invested in this life-saving and cost-cutting tool.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Spectral AI Inc.
Spectral AI uses artificial intelligence to assess burn severity. Its market value is based on its unique technology, which could radically improve physician decision-making. Investors are paying for the potential to become a new standard in burn treatment.
Market to book capitalization ratio in a market segment - AI
Spectral AI uses artificial intelligence to assess burn severity, helping doctors make treatment decisions. Its value lies in its unique algorithm and device. This chart shows the premium investors are paying for its breakthrough technology, which could become a new standard in medicine.
Market to book capitalization ratio for the market as a whole
Spectral AI uses artificial intelligence to assess the severity of burns and wounds. The company's value lies in its unique technology, algorithms, and patent portfolio. This chart demonstrates the high premium the market is willing to pay for cutting-edge solutions at the intersection of AI and medicine, despite the modest book value of its tangible assets.
Debts of the company, segment and market as a whole
MDAI - Company debts Spectral AI Inc.
Spectral AI uses artificial intelligence to assess burn severity, which could revolutionize emergency medicine. Commercialization of this device requires investment in production and marketing. Debt financing could be used to scale operations and bring this technology to hospitals.
Market segment debts - AI
Spectral AI, Inc. uses artificial intelligence to analyze wound images to assist physicians in decision-making. Developing and commercializing medical AI requires investment in R&D and clinical validation. This chart shows how the company is funding this process to bring its technology to market and integrate it into hospital workflows.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Spectral AI Inc.
Spectral AI uses artificial intelligence for medical diagnostics, specifically burn assessment. This chart shows how the company finances its innovative developments. A high debt load for a medical technology startup is a bet that their technology will be quickly adopted by the market and regulators, otherwise, the debt could sink them.
Market segment debt to market segment book capitalization - AI
Spectral AI is developing an AI-powered medical device for rapid burn assessment, helping doctors make treatment decisions. This chart compares the company's debt required to commercialize this technology to the overall market capitalization of the AI โโsector. It reflects the financial risks of implementing AI in a conservative medical environment.
Debt to book value of all companies in the market
Spectral AI uses artificial intelligence for medical diagnostics, specifically burn assessment. The development and implementation of such technologies requires significant investment. The chart shows how the company finances its innovations. Its debt load, compared to the AI โโand MedTech sectors, reflects the balance between rapid growth and financial risk.
P/E of the company, segment and market as a whole
P/E - Spectral AI Inc.
For Spectral AI, a company using artificial intelligence to assess burns, this chart is a bet on a revolution in emergency medicine. The high price per dollar of future revenue reflects the hope that its technology will enable doctors to make more accurate decisions. The trend reflects progress in securing approvals and implementing the device in hospitals.
P/E of the market segment - AI
This chart reflects the collective expectations of the entire medical AI industry, of which Spectral AI is a player. High average valuations are the norm for this sector. For investors, this benchmark raises the question of whether Spectral AI's valuation matches or exceeds the overall level of faith in AI-based diagnostic technologies.
P/E of the market as a whole
Spectral AI uses artificial intelligence to analyze wound images to help doctors make more informed treatment decisions, particularly for burns. This is an innovative application of AI in medicine. This chart reflects market sentiment and helps understand how the market views Spectral AI technology's potential to improve treatment outcomes and reduce costs in healthcare.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Spectral AI Inc.
Spectral AI uses artificial intelligence for medical diagnostics, specifically to assess burn severity. The company's future profitability depends on the commercialization of its DeepView device. This chart shows whether analysts believe this technology will be adopted by the medical community and will improve the standard of care for burn patients.
Future (projected) P/E of the market segment - AI
Spectral AI is developing an AI-powered medical device for quickly and accurately assessing burn severity. This chart compares its future profitability expectations with those of the medical technology sector. It helps understand how much investors believe in its ability to transform the standard of care for burn patients and commercialize its technology.
Future (projected) P/E of the market as a whole
Spectral AI uses artificial intelligence for medical diagnostics, specifically burn assessment. This chart shows the overall sentiment in the tech and medical sectors. For Spectral AI, the focus isn't on economics, but rather on gaining regulatory approval and proving that their technology improves treatment outcomes and reduces costs.
Profit of the company, segment and market as a whole
Company profit Spectral AI Inc.
Spectral AI is developing an AI-powered medical device for rapid burn and wound assessment. This technology helps doctors make more accurate treatment decisions. This chart shows the company's financial results as it commercializes its breakthrough diagnostic system.
Profit of companies in the market segment - AI
Spectral AI is developing an AI-powered medical device for rapid and accurate burn and wound assessment. The technology helps doctors make treatment decisions in real time. This chart reflects the financial dynamics of the medical AI sector, demonstrating how AI is being integrated into medical practice to improve outcomes.
Overall market profit
Spectral AI is developing an AI-based medical device for burn severity assessment. The adoption of this innovative technology depends on its clinical effectiveness and cost-effectiveness for hospitals. Demand is determined by the needs of the healthcare system, not by general economic cycles.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Spectral AI Inc.
Spectral AI is developing an AI-powered medical device for burn severity assessment, helping doctors make treatment decisions. This graph reflects analysts' expectations for how quickly and widely this innovative technology will be implemented in burn centers.
Future (predicted) profit of companies in the market segment - AI
Spectral AI is developing an AI-powered medical device for burn severity assessment, helping doctors make more informed treatment decisions. This chart shows forecasts for the medical AI sector. Spectral AI's profitability depends on the commercialization of its technology, which promises to improve patient outcomes and reduce costs.
Future (predicted) profit of the market as a whole
Spectral AI is developing an AI-based medical diagnostic platform for wound assessment. The adoption of such technologies depends on the willingness of healthcare institutions to invest in innovation. This graph, showing corporate profit projections, is an indicator of overall economic health, which impacts healthcare budgets and the adoption of new technologies.
P/S of the company, segment and market as a whole
P/S - Spectral AI Inc.
Spectral AI uses artificial intelligence for medical diagnostics, specifically to assess burn severity. This chart shows how highly investors rate its innovative technology, reflecting their belief that AI can dramatically improve clinical decision-making and patient outcomes.
P/S market segment - AI
Spectral AI uses artificial intelligence to analyze wound images to help doctors make more accurate treatment decisions for burns and other wounds. This helps avoid unnecessary surgeries. This chart shows how the market values โโcompanies in the medical AI space, helping to understand the potential of Spectral AI technology to improve treatment outcomes and reduce costs.
P/S of the market as a whole
Spectral AI has developed an AI-powered device to assist in burn and wound diagnosis, enabling doctors to make more informed treatment decisions. This average market valuation indicator shows how highly investors value companies that use AI to solve real-world medical problems and improve patient outcomes.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Spectral AI Inc.
Spectral AI is developing an AI-powered medical device that helps doctors assess burn severity and make treatment decisions. This chart reflects investors' confidence in the commercial potential of this technology. The valuation is based on expected future revenue from sales of the device to hospitals and burn centers.
Future (projected) P/S of the market segment - AI
Spectral AI is developing an AI-powered medical device for burn severity assessment. This chart compares the company's future revenue expectations with its industry. It reflects investors' belief that this technology will transform burn care standards and be widely adopted by hospitals.
Future (projected) P/S of the market as a whole
Spectral AI is developing an AI-powered medical device for the rapid and accurate assessment of burn wounds. The optimism expressed by this indicator is fueled by innovation in medicine. Spectral AI technology has the potential to radically change the standards of burn treatment, and its implementation is an indicator of digitalization in diagnostics.
Sales of the company, segment and market as a whole
Company sales Spectral AI Inc.
Spectral AI is developing an AI-powered medical device for burn severity assessment. While awaiting regulatory approval, the company generates revenue primarily from government research and development contracts rather than from commercial sales of its product.
Sales of companies in the market segment - AI
Spectral AI has developed an AI-powered system for assessing burn severity, helping doctors make more accurate treatment decisions. Their technology could become a new standard in burn care. This chart illustrates the growth of the medical technology market, where AI like Spectral's has the potential to dramatically improve the quality of care.
Overall market sales
Spectral AI, Inc. is developing an AI-powered medical device for wound healing analysis. The implementation of such technologies depends on hospital budgets. The increase in overall economic revenue, reflected in this graph, improves healthcare system funding. This allows clinics to invest in innovative tools that can improve patient care and reduce costs.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Spectral AI Inc.
Spectral AI, Inc. has developed a portable AI-powered device that helps doctors assess burn severity and make treatment decisions in real time. This graph shows analysts' expectations for the commercialization of this technology and its implementation in burn centers and emergency departments.
Future (projected) sales of companies in the market segment - AI
Spectral AI is developing an AI-powered medical device for rapid and accurate burn wound assessment, helping doctors make treatment decisions. This chart shows forecasts for the AI โโsector in medicine, illustrating how machine learning technologies are transforming diagnostics and improving patient outcomes.
Future (projected) sales of the market as a whole
Spectral AI, which uses artificial intelligence for wound assessment, sees this chart as an indicator of the adoption of advanced technologies in medicine. The economic growth reflected here allows hospitals and burn centers to invest in innovative diagnostic tools that improve the quality and speed of clinical decision-making.
Marginality of the company, segment and market as a whole
Company marginality Spectral AI Inc.
Spectral AI is developing an AI-powered medical device for wound analysis to help doctors make treatment decisions. The company is incurring significant expenses as it moves toward commercialization. This chart shows its financial position, reflecting the balance between R&D investments and the initial steps toward turning the technology into a profitable product.
Market segment marginality - AI
Spectral AI uses artificial intelligence for medical diagnostics, specifically to assess burn severity. Profitability in AI medicine depends on the accuracy of its algorithms and their successful integration into clinical practice. The chart shows how effective the company's business model is compared to other diagnostic technology developers.
Market marginality as a whole
Spectral AI uses artificial intelligence to analyze wound images to help doctors make burn treatment decisions. Given the overall profitability data, Spectral AI operates at the intersection of medicine and AI. Their profitability will depend on the accuracy of their device and its implementation in burn centers to improve patient outcomes.
Employees in the company, segment and market as a whole
Number of employees in the company Spectral AI Inc.
Spectral AI uses artificial intelligence for medical diagnostics, specifically burn assessment. This graph shows its team of engineers, AI specialists, and clinicians. The staff growth reflects progress in the development and commercialization of its portable DeepView device.
Share of the company's employees Spectral AI Inc. within the market segment - AI
Spectral AI is developing an AI-powered medical device for rapid burn and wound assessment. This chart shows the percentage of specialists at the intersection of artificial intelligence and medicine the company is attracting. It reflects its innovative approach and potential to transform emergency care standards with cutting-edge technology.
Number of employees in the market segment - AI
Spectral AI is developing an AI-powered medical device for burn severity assessment. Its staff consists of engineers, AI specialists, and clinicians. This timeline shows the company's progress toward commercialization. Growth of the team, particularly in sales and support, will signal regulatory approval and market entry.
Number of employees in the market as a whole
Spectral AI uses artificial intelligence to assess burn severity, accelerating clinical decision-making. The MedTech sector, especially with AI, is growing explosively. This chart shows the overall economic picture, but for Spectral AI, the main driver is the technological revolution in medicine.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Spectral AI Inc. (MDAI)
Spectral AI uses AI for medical diagnostics. It's a tech company whose main assets are software and algorithms. This chart should show a high capitalization per employee, as its product is easily scalable. This is the value of intellectual capital.
Market capitalization per employee (in thousands of dollars) in the market segment - AI
Spectral AI, Inc. uses artificial intelligence for medical diagnostics, specifically to assess wound healing. For a medical AI company, this metric reflects investors' confidence in the accuracy and commercial potential of its algorithms. The chart shows how highly the market values โโits technology relative to its team of developers and physicians.
Market capitalization per employee (in thousands of dollars) for the overall market
Spectral AI uses artificial intelligence to analyze wound images to help doctors determine the need for surgical intervention. The company is at the intersection of medicine and AI. The chart shows how the market perceives the potential of this breakthrough technology, where algorithms created by a small team can improve treatment outcomes for thousands of patients.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Spectral AI Inc. (MDAI)
Spectral AI is developing a medical device (DeepView) that uses AI to analyze burn wounds and assist surgeons. This is the intersection of AI and medicine. This graph shows how far the company is moving toward commercialization. It reflects how much revenue (or R&D costs) each employee generating for the development and marketing of this innovative technology generates.
Profit per employee (in thousands of dollars) in the market segment - AI
Spectral AI (MDAI) develops AI-powered medical diagnostic technology, specifically the "DeepView" device for burn and wound assessment. It combines AI with medical equipment. This chart shows how effectively the company is moving toward commercialization, converting R&D costs (engineers, data scientists) into future revenue from device sales.
Profit per employee (in thousands of dollars) for the market as a whole
Spectral AI uses artificial intelligence for medical diagnostics, specifically to assess burn severity. It's a hybrid of MedTech and AI. This graph shows how close the company is to commercialization. While development and clinical trials are ongoing, the profit per employee (AI engineer, physician) will be low or negative. Success will mean high scalability: the software is easy to replicate.
Sales to employees of the company, segment and market as a whole
Sales per company employee Spectral AI Inc. (MDAI)
Spectral AI uses artificial intelligence to assess the severity of burns and wounds. This graph illustrates how cutting-edge technology can be commercialized in medicine. Increasing revenue per employee will mean their device becomes more widely used in hospitals, helping doctors make more accurate decisions.
Sales per employee in the market segment - AI
Spectral AI is developing an AI-powered medical device (DeepView) that helps doctors assess burn severity in real time. It represents the intersection of AI and MedTech. This graph shows the average revenue per employee in the sector, demonstrating how productive the Spectral AI team is in bringing their innovative diagnostic device to market.
Sales per employee for the market as a whole
Spectral AI, Inc. (MDAI) is developing DeepView, an AI-powered medical device that helps doctors assess burn depth in real time. This is expected to improve treatment outcomes. This chart shows the company's progress in commercializing this innovative diagnostic system, measured per employee.
Short shares by company, segment and market as a whole
Shares shorted by company Spectral AI Inc. (MDAI)
Spectral AI uses AI to assess wound healing (burns), helping doctors make treatment decisions. The company went public through a SPAC. This chart shows the number of "bears" betting that this technology will not be adopted by the medical community or that hospitals will not see the economic benefit of purchasing this expensive equipment.
Shares shorted by market segment - AI
Spectral AI uses artificial intelligence to analyze wound images, helping doctors make decisions. This chart measures the overall skepticism in the sector. It shows how skeptical investors are that AI diagnostics will be quickly adopted by hospitals or reimbursed by insurers, which is holding back the entire industry.
Shares shorted by the overall market
Spectral AI uses artificial intelligence to diagnose wounds, promising to revolutionize patient care. It's a hot topic, but the company is still on the road to commercialization. When this chart shows rising fear, investors begin to doubt hyped-up sectors like AI. They're looking for real profits, not forecasts, which is putting pressure on MDAI shares.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Spectral AI Inc. (MDAI)
Spectral AI uses artificial intelligence to assess wounds, helping doctors make burn treatment decisions. It's a breakthrough technology in medicine. This indicator measures the speed at which investors are "buying" into the story, signaling "overheating" (above 70) or moments when faith in the technology temporarily weakens (below 30).
RSI 14 Market Segment - AI
Spectral AI (MDAI) is "AI" for *wounds*. Their *device* (DeepView) uses *AI* to *instantly* assess the *severity* of burns* (to prevent doctors from making mistakes). The "AI" (AI/medtech) sector is fueled by hype. RSI\_14\_Seg is a clear indicator of the "hype" in the industry. It helps us understand: is MDAI's growth due to their AI platform, or is the *entire* sector "overheated"?
RSI 14 for the overall market
Spectral AI (MDAI) is pure hype. This chart demonstrates the appetite for speculation. During periods of market euphoria, investors are ready to "buy the dream" and invest in any company with the word "AI" in its name. In moments of panic, investors flee unprofitable "concepts," and these stocks are the first to be sold off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast MDAI (Spectral AI Inc.)
Spectral AI (MDAI) is developing an AI-powered medical device (DeepView) that helps doctors assess the severity of burns and wounds. This graph shows the average 12-month forecast. It reflects analysts' expectations for the commercialization of this technology and its implementation in burn centers.
The difference between the consensus estimate and the actual stock price MDAI (Spectral AI Inc.)
Spectral AI (MDAI) is a medical technology company that uses AI (DeepView) to analyze burns and wounds, helping doctors make treatment decisions. This chart is a barometer of their R&D. It measures the gap between the price and the consensus target, reflecting whether analysts believe their AI diagnostics will be adopted by hospitals and receive FDA approval.
Analyst consensus forecast for stock prices by market segment - AI
Spectral AI is a medical company that uses AI to analyze burns. Their device (DeepView) "sees" beneath the skin, helping surgeons determine burn depth and salvage healthy tissue. This chart shows analysts' overall expectations for the AI โโsector, reflecting whether experts believe the "AI diagnostics" market in surgery will grow.
Analysts' consensus forecast for the overall market share price
Spectral AI is developing AI for diagnostic "wound care." It's a 100% "speculative" story, combining AI and medtech. This chart, reflecting the market's "risk appetite," is vital. When optimism is high, investors fund "dream projects." When pessimism ("risk-off") takes over, funding for cash-burning companies like MDAI dries up.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Spectral AI Inc.
Spectral AI is a MedTech company that sees what the eye cannot. They have developed a portable device (DeepView) that uses AI and multispectral imaging to assess burn and wound severity, helping surgeons make decisions. This graph is a summary of their commercialization progress, reflecting their progress toward FDA approval and their potential to become a standard in burn centers.
AKIMA Market Segment Index - AI
Spectral AI (MDAI) is developing DeciScan, an AI-powered medical diagnostic platform designed to help doctors assess burns and wounds, predicting their healing potential. The chart shows the average index for the segment, helping investors assess the potential of this innovative AI diagnostics compared to the AdTech/AI sector average.
The AKIM Index for the overall market
Spectral AI is a company using AI to diagnose and treat wounds (burns, diabetic ulcers). DeepView system. This chart, reflecting the market average, is just a background. It helps assess how this innovative medical technology, backed by the US government, compares to overall macroeconomic trends.